Threat watch / Attack
Myriad Genetics: network intrusion suspends genetic testing and order systems
On November 2, US genetic testing company Myriad Genetics "detected unauthorized access within its information technology network environment". It temporarily suspended its testing operations and order management systems and reset certain credentials. In a filing with the SEC on November 5, it says most systems are back and that it is still assessing whether patient records were accessed.
- Sector
- Health
- Way in
- Not public yet
- Product or vendor
- None named
- How it happened
- Not public yet Checked 9 Nov 2026
- What was stolen
- Not public yet Checked 9 Nov 2026
- Who was impacted
- Myriad Genetics' testing operations and order management, suspended while the company responded. Whether patient records were accessed is still under investigation, the company says.[1] Checked 9 Nov 2026
- Threat actor
- Not attributed
Timeline
- Myriad Genetics detects unauthorized access in its IT network, starts its incident response, temporarily suspends testing operations and order management systems, and resets certain system credentials. [1]
- In a Form 8-K filed with the SEC, the company says "most of the Company's systems have returned to normal operations", that the full scope is still under investigation, including "whether any patient records were accessed", and that it does not expect a material adverse effect on its business. [1]